These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 17553151

  • 1. Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.
    Mody RM, Erwin DP, Summers AM, Carrero HA, Selby EB, Ewell AJ, Moran KA.
    Ann Clin Microbiol Antimicrob; 2007 Jun 06; 6():6. PubMed ID: 17553151
    [Abstract] [Full Text] [Related]

  • 2. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C, Yetkin F, Görgeç S, Ersoy Y.
    Mikrobiyol Bul; 2011 Jan 06; 45(1):28-35. PubMed ID: 21341156
    [Abstract] [Full Text] [Related]

  • 3. Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India.
    Behera B, Mathur P, Das A, Kapil A.
    Singapore Med J; 2009 Jun 06; 50(6):628-32. PubMed ID: 19551319
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.
    Kiremitci A, Dinleyici EC, Erben N, Durmaz G, Yargic ZA, Aybey AD, Usluer G.
    Expert Opin Pharmacother; 2008 Jun 06; 9(9):1441-9. PubMed ID: 18518776
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Moczygemba LR, Frei CR, Burgess DS.
    Clin Ther; 2004 Nov 06; 26(11):1800-7. PubMed ID: 15639692
    [Abstract] [Full Text] [Related]

  • 6. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K, Wong SS, Lin LC, Tsai CR, Chen LC, Huang CH.
    J Microbiol Immunol Infect; 2012 Jun 06; 45(3):193-9. PubMed ID: 22580086
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009).
    Hawser SP, Bouchillon SK, Lascols C, Hackel M, Hoban DJ, Badal RE, Cantón R.
    Clin Microbiol Infect; 2012 Mar 06; 18(3):253-9. PubMed ID: 21635662
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
    Hernández JR, Velasco C, Romero L, Martínez-Martínez L, Pascual A.
    Int J Antimicrob Agents; 2006 Nov 06; 28(5):457-9. PubMed ID: 17008066
    [Abstract] [Full Text] [Related]

  • 9. Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Lee NY, Huang WH, Tsui KC, Hsueh PR, Ko WC.
    Diagn Microbiol Infect Dis; 2011 May 06; 70(1):150-3. PubMed ID: 21398070
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ.
    J Microbiol Immunol Infect; 2011 Oct 06; 44(5):364-8. PubMed ID: 21524974
    [Abstract] [Full Text] [Related]

  • 11. Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi.
    Taneja J, Mishra B, Thakur A, Dogra V, Loomba P.
    J Infect Dev Ctries; 2010 Sep 03; 4(8):517-20. PubMed ID: 20818104
    [Abstract] [Full Text] [Related]

  • 12. Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model.
    DeRyke CA, Banevicius MA, Fan HW, Nicolau DP.
    Antimicrob Agents Chemother; 2007 Apr 03; 51(4):1481-6. PubMed ID: 17283197
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany.
    Wienke M, Pfeifer Y, Weissgerber P, Marschal M, Autenrieth IB, Gröbner S.
    Chemotherapy; 2012 Apr 03; 58(3):241-8. PubMed ID: 22832033
    [Abstract] [Full Text] [Related]

  • 14. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group.
    J Clin Microbiol; 2007 Jan 03; 45(1):199-205. PubMed ID: 17079502
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan 03; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 16. [In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase].
    Villar HE, Jugo MB, Visser M, Hidalgo M, Hidalgo G, Maccallini GC.
    Rev Esp Quimioter; 2014 Mar 03; 27(1):51-5. PubMed ID: 24676243
    [Abstract] [Full Text] [Related]

  • 17. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Bishara J, Livne G, Ashkenazi S, Levy I, Pitlik S, Ofir O, Lev B, Samra Z.
    Isr Med Assoc J; 2005 May 03; 7(5):298-301. PubMed ID: 15909461
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S.
    P R Health Sci J; 2004 Sep 03; 23(3):207-15. PubMed ID: 15631176
    [Abstract] [Full Text] [Related]

  • 20. Pharmacodynamic profiling of imipenem, meropenem and ertapenem against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. from Brazil.
    Kiffer CR, Kuti JL, Eagye KJ, Mendes C, Nicolau DP.
    Int J Antimicrob Agents; 2006 Oct 03; 28(4):340-4. PubMed ID: 16930951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.